Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian Gifford

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Methods in Molecular Medicine|April 6, 2004
Microsatellite instability: theory and methodsGillian Gifford, Robert Brown
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patientsGillian Gifford, Jim Paul, Paul A Vasey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
ABCB1 2677G>T/A genotype and paclitaxel pharmacogenetics in ovarian cancerSharon Marsh, Cristi R King, Howard L McLeod, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian CancerSharon Marsh, Jim Paul, Cristi R King, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Prognostic DNA methylation biomarkers in ovarian cancerSusan H Wei, Curtis Balch, Henry H Paik, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Methods in Molecular Medicine|April 6, 2004
Microsatellite instability: theory and methodsGillian Gifford, Robert Brown
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2004
The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patientsGillian Gifford, Jim Paul, Paul A Vasey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
ABCB1 2677G>T/A genotype and paclitaxel pharmacogenetics in ovarian cancerSharon Marsh, Cristi R King, Howard L McLeod, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2007
Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian CancerSharon Marsh, Jim Paul, Cristi R King, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Prognostic DNA methylation biomarkers in ovarian cancerSusan H Wei, Curtis Balch, Henry H Paik, et al.
Pageof 1